Profil
Eugene Berezikov is the founder of InteRNA Technologies BV, which was founded in 2006.
Currently, he is a Group Leader at Hubrecht Institute.
Aktive Positionen von Eugene Berezikov
Unternehmen | Position | Beginn |
---|---|---|
Hubrecht Institute
Hubrecht Institute BiotechnologyHealth Technology The Hubrecht Institute is a research institute that focuses on fundamental, multidisciplinary research on healthy and diseased cells, tissues, and organisms. The location of the private company is in Utrecht, Netherlands. The institute encompasses 23 research groups dedicated to this mission. | Corporate Officer/Principal | 15.04.2010 |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Gründer | 01.12.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Hubrecht Institute
Hubrecht Institute BiotechnologyHealth Technology The Hubrecht Institute is a research institute that focuses on fundamental, multidisciplinary research on healthy and diseased cells, tissues, and organisms. The location of the private company is in Utrecht, Netherlands. The institute encompasses 23 research groups dedicated to this mission. | Health Technology |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Health Technology |